Lymphoma, Large Cell Completed Phase 2 Trials for Rituximab (DB00073)

Also known as: Large Cell Lymphoma / Lymphoma, Large-Cell / Large-cell Lymphoma

IndicationStatusPhase
DBCOND0032452 (Lymphoma, Large Cell)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01118845Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell LymphomaTreatment